-
1
-
-
84860209263
-
-
Anonymous Genentech, South San Francisco, CA
-
Anonymous. 2010. Rocephin package insert. Genentech, South San Francisco, CA.
-
(2010)
Rocephin Package Insert
-
-
-
2
-
-
33645766499
-
Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: Identification of an in vivo pharmacokinetic-pharmacodynamic target
-
Andes D, Craig WA. 2006. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target. Antimicrob. Agents Chemother. 50:1376-1383.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 1376-1383
-
-
Andes, D.1
Craig, W.A.2
-
3
-
-
0021832112
-
In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives
-
Blaser J. 1985. In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J. Antimicrob. Chemother. 15(Suppl A):125-130. (Pubitemid 15079556)
-
(1985)
Journal of Antimicrobial Chemotherapy
, vol.15
, Issue.SUPPL. A
, pp. 125-130
-
-
Blaser, J.1
-
4
-
-
0344874267
-
Linezolid, Levofloxacin, and Vancomycin Against Vancomycin-Tolerant and Fluoroquinolone-Resistant Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model
-
DOI 10.1592/phco.23.15.1531.31964
-
Cha R, Akins RL, Rybak MJ. 2003. Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model. Pharmacotherapy 23:1531-1537. (Pubitemid 37485304)
-
(2003)
Pharmacotherapy
, vol.23
, Issue.12 I
, pp. 1531-1537
-
-
Cha, R.1
Akins, R.L.2
Rybak, M.J.3
-
5
-
-
79954622204
-
Review of ceftaroline fosamil microbiology: Integrated FOCUS studies
-
Critchley IA, et al. 2011. Review of ceftaroline fosamil microbiology: integrated FOCUS studies. J. Antimicrob. Chemother. 66(Suppl 3): iii45-51.
-
(2011)
J. Antimicrob. Chemother.
, vol.66
, Issue.SUPPL. 3
-
-
Critchley, I.A.1
-
6
-
-
79959236262
-
Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing
-
Croisier-Bertin D, et al. 2011. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing. Antimicrob. Agents Chemother. 55:3557-3563.
-
(2011)
Antimicrob. Agents Chemother.
, vol.55
, pp. 3557-3563
-
-
Croisier-Bertin, D.1
-
7
-
-
68349086854
-
Emergence of Streptococcus pneumoniae of serotype 19A in France: Molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology
-
Dortet L, Ploy MC, Poyart C, Raymond J. 2009. Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology. Diagn. Microbiol. Infect. Dis. 65:49-57.
-
(2009)
Diagn. Microbiol. Infect. Dis.
, vol.65
, pp. 49-57
-
-
Dortet, L.1
Ploy, M.C.2
Poyart, C.3
Raymond, J.4
-
8
-
-
55849104841
-
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime
-
Fenoll A, et al. 2008. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime. Antimicrob. Agents Chemother. 52:4209-4210.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 4209-4210
-
-
Fenoll, A.1
-
9
-
-
78649873377
-
Integrated analysis of FOCUS 1 and FOCUS 2: Randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia
-
File TM, Jr, et al. 2010. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin. Infect. Dis. 51:1395-1405.
-
(2010)
Clin. Infect. Dis.
, vol.51
, pp. 1395-1405
-
-
File Jr., T.M.1
-
10
-
-
79954622500
-
FOCUS 1: A randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
-
File TM, Jr, et al. 2011. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. J. Antimicrob. Chemother. 66(Suppl 3):iii19-32.
-
(2011)
J. Antimicrob. Chemother.
, vol.66
, Issue.SUPPL. 3
-
-
File Jr., T.M.1
-
11
-
-
84860121748
-
-
The pharmacokinetics (PK) and safety of ceftaroline (PPI-0903) in healthy subjects receiving multiple-dose intravenous (IV) infusions, poster A1937
-
Ge, JY, Redman R, Floren L, Liao S, Wikler M. 2006. The pharmacokinetics (PK) and safety of ceftaroline (PPI-0903) in healthy subjects receiving multiple-dose intravenous (IV) infusions, poster A1937. 47th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA, 27 to 30 September 2006.
-
(2006)
47th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA, 27 to 30 September 2006
-
-
Ge, J.Y.1
Redman, R.2
Floren, L.3
Liao, S.4
Wikler, M.5
-
12
-
-
50949105050
-
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States
-
Ge Y, Biek D, Talbot GH, Sahm DF. 2008. In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States. Antimicrob. Agents Chemother. 52:3398-3407.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 3398-3407
-
-
Ge, Y.1
Biek, D.2
Talbot, G.H.3
Sahm, D.F.4
-
13
-
-
55849108870
-
Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine
-
Jacobs MR, Good CE, Bajaksouzian S, Windau AR. 2008. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin. Infect. Dis. 47:1388-1395.
-
(2008)
Clin. Infect. Dis.
, vol.47
, pp. 1388-1395
-
-
Jacobs, M.R.1
Good, C.E.2
Bajaksouzian, S.3
Windau, A.R.4
-
14
-
-
40749096040
-
Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: A quarter century of experience
-
DOI 10.1128/JCM.02321-07
-
Jacobs MR, et al. 2008. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J. Clin. Microbiol. 46:982-990. (Pubitemid 351379990)
-
(2008)
Journal of Clinical Microbiology
, vol.46
, Issue.3
, pp. 982-990
-
-
Jacobs, M.R.1
Good, C.E.2
Beall, B.3
Bajaksouzian, S.4
Windau, A.R.5
Whitney, C.G.6
-
15
-
-
73649093453
-
Etiology of community-acquired pneumonia: Increased microbiological yield with new diagnostic methods
-
Johansson, N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. 2010. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin. Infect. Dis. 50:202-209.
-
(2010)
Clin. Infect. Dis.
, vol.50
, pp. 202-209
-
-
Johansson, N.1
Kalin, M.2
Tiveljung-Lindell, A.3
Giske, C.G.4
Hedlund, J.5
-
16
-
-
77957892620
-
Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: Report from the SENTRY Antimicrobial Surveillance Program (1998-2009)
-
Jones RN, Sader HS, Moet GJ, Farrell DJ. 2010. Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009). Diagn. Microbiol. Infect. Dis. 68:334-346.
-
(2010)
Diagn. Microbiol. Infect. Dis.
, vol.68
, pp. 334-346
-
-
Jones, R.N.1
Sader, H.S.2
Moet, G.J.3
Farrell, D.J.4
-
17
-
-
79954622500
-
FOCUS 2: A randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
-
Low DE, et al. 2011. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. J. Antimicrob. Chemother. 66(Suppl 3):iii33-44.
-
(2011)
J. Antimicrob. Chemother.
, vol.66
, Issue.SUPPL. 3
-
-
Low, D.E.1
-
18
-
-
59749096800
-
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae
-
McGee L, et al. 2009. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 53:552-556.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 552-556
-
-
McGee, L.1
-
19
-
-
77952578858
-
Binding of ceftaroline in penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae
-
Moisan H, Pruneau M, Malouin F. 2010. Binding of ceftaroline in penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae. J. Antimicrob. Chemother. 65:713-716.
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, pp. 713-716
-
-
Moisan, H.1
Pruneau, M.2
Malouin, F.3
-
20
-
-
64549135399
-
Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia
-
Morrissey I, Ge Y, Janes R. 2009. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia. Int. J. Antimicrob. Agents 33:515-519.
-
(2009)
Int. J. Antimicrob. Agents
, vol.33
, pp. 515-519
-
-
Morrissey, I.1
Ge, Y.2
Janes, R.3
-
21
-
-
63849299150
-
Making sense of scoring systems in community acquired pneumonia
-
Niederman MS. 2009. Making sense of scoring systems in community acquired pneumonia. Respirology 14:327-335.
-
(2009)
Respirology
, vol.14
, pp. 327-335
-
-
Niederman, M.S.1
-
22
-
-
0034959819
-
Guidelines for the management of adults with community-acquired pneumonia diagnosis, assessment of severity, antimicrobial therapy, and prevention
-
Niederman MS, et al. 2001. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Resp. Crit. Care Med. 163: 1730-1754. (Pubitemid 32578779)
-
(2001)
American Journal of Respiratory and Critical Care Medicine
, vol.163
, Issue.7
, pp. 1730-1754
-
-
Niederman, M.S.1
Mandell, L.A.2
Anzueto, A.3
Bass, J.B.4
Broughton, W.A.5
Campbell, G.D.6
Dean, N.7
File, T.8
Fine, M.J.9
Gross, P.A.10
Martinez, F.11
Marrie, T.J.12
Plouffe, J.F.13
Ramirez, J.14
Sarosi, G.A.15
Torres, A.16
Wilson, R.17
Yu, V.L.18
-
23
-
-
0037159564
-
The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections
-
DOI 10.1016/S0002-9343(02)01162-2, PII S0002934302011622
-
Pallares R, et al. 2002. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. Am. J. Med. 113:120-126. (Pubitemid 34804748)
-
(2002)
American Journal of Medicine
, vol.113
, Issue.2
, pp. 120-126
-
-
Pallares, R.1
Capdevila, O.2
Linares, J.3
Grau, I.4
Onaga, H.5
Tubau, F.6
Schulze, M.H.7
Hohl, P.8
Gudiol, F.9
-
24
-
-
34249813721
-
Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine
-
DOI 10.1097/INF.0b013e31803df9ca, PII 0000645420070600000003
-
Pelton SI, et al. 2007. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 26:468-472. (Pubitemid 46847304)
-
(2007)
Pediatric Infectious Disease Journal
, vol.26
, Issue.6
, pp. 468-472
-
-
Pelton, S.I.1
Huot, H.2
Finkelstein, J.A.3
Bishop, C.J.4
Hsu, K.K.5
Kellenberg, J.6
Huang, S.S.7
Goldstein, R.8
Hanage, W.P.9
-
25
-
-
77950274114
-
Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas
-
Techasaensiri C, Jr, et al. 2010. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr. Infect. Dis. J. 29:294-300.
-
(2010)
Pediatr. Infect. Dis. J.
, vol.29
, pp. 294-300
-
-
Techasaensiri Jr., C.1
-
26
-
-
70350498834
-
Pathogenesis, treatment, and prevention of pneumococcal pneumonia
-
van der Poll T, Opal SM. 2009. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374:1543-1556.
-
(2009)
Lancet
, vol.374
, pp. 1543-1556
-
-
Van Der Poll, T.1
Opal, S.M.2
|